Russian Heart Failure Journal 2010year Problems and prospects of cardiac resynchronization therapy in patients with chronic heart failure

To access this material please log in or register

Register Authorize

Problems and prospects of cardiac resynchronization therapy in patients with chronic heart failure

Atroshchenko E. S.

Keywords: myocardial remodeling, resynchronization, CHF

DOI: 10.18087/rhfj.2010.2.1261

Nowdays indications for resinhroniziruyuschey therapy (RT) are well-defined in the most severe group of patients with CHF. But accumulated experience allows to pose the question of expanding the indications for RT, to identify responders and non-responders.
  1. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352 (15):1539–1549.
  2. Valzania C, Gadler F, Erksson M et al. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patiets with heart failure. Eur J Heart Fail. 2007;9 (6-7):644–650.
  3. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346 (24):1845–1853.
  4. Auricchio A, Stellbrink C, Sack S et al. Pasing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimised cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002;39 (12):2026–2033.
  5. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350 (21):2140–2150.
  6. Cazeau S, Leclercq C, Lavergne T et al. Multisite stimulation in Cardio­myopathies (MUSTIC) Study Investigators. Effect of multisite biventricular pacing inpathients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344 (12):873–880.
  7. Vardas PE, Auricchio A, Blanc JJ et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007;28 (18):2256–2295.
  8. Cleland JG, Daubert JC, Erdmann E et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006;27 (16):1928–1932.
  9. Lindner O, Vogt J, Baller D et al. Gobal and regional myocardial oxygen consumption and blood flou in severe cardiomyopathy with left bungle branch block. Eur J Heart Fail. 2005;7 (2):225–230.
  10. Lancellotti P, Mélon P, Sakalihasan N et al. Effect of cardiac resynchronization therapy on fuctional mitral regurgitation in heart failure. Am J Cardiol. 2004;94 (11):1462–1465.
  11. Turner MS, Bleasdale RA, Vinereanu D et al. Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle branch block: impact of left and biventricular pasing. Circulation. 2004;109 (21):2544–2549.
  12. Wong SP, French JK, Lydon AM et al. Relation of left ventricular sphericity to 10‑yers survival after acute myocardial infarction. Am J Cardiol. 2004;94 (10):1270–1275.
  13. Donal E, Leclercq C, Linde C, Daubert JC. Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J. 2006;27 (9):1018–1025.
  14. Spragg DD, Leclercov C, Logmani M et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108 (8):929–932.
  15. Kurita T, Onishi K, Dohi K et al. Impact of heart rate on mechanical dyssynchrony and left ventricular contractility in patients with heart failure normal QRS duration. Eur J Heart Fail. 2007;9 (6-7):637–643.
  16. Kourouklis S, Manolis AG. Cardiac resychronization therapy in asymptomatic and mildly symptomatic chronic systolic heart failure: A new era of systolic heart failure management? Hellenic J Cardiol. 200;49 (5):349–351.
  17. Andrikopoulos GK, Tzeis S, Manolis AS. Cardiac resynchronization therapy in heart failure patients with narrow QRS complex:quo vadis? Hellenic J Cardiol. 2007;48 (6):315–318.
  18. Karagiannis SE, Maounis T, Athanassopoulos GD et al. Cardiac resynchronization therapy decreases the mitral coaptation point displacement in heart failure patients. Hellenic J Cardiol. 2006;47 (4):198–205.
  19. Baldasseroni S, Gentile A, Gorini M et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). Ital Heart J. 2003;4 (9):607–613.
  20. Kalra PR, Sharma R, Shamim W et al. Clinical characteristic and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol. 2002;86 (2-3):225–231.
  21. Yu CM, Bleeker GB, Fung JW et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112 (11):1580–1586.
  22. Da Costa A, Thévenin J, Roche F et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm. 2006;3 (4):406–413.
  23. Urheim S, Edvardsen T, Torp H et al. Myocardial strain by Dopper echocardiography. Validation of a new method to quantify regional myocardial function. Circulation. 2000;102 (10):1158–1164.
  24. Greenberg NL, Fistenberg MS, Castro PL et al. Doppler-derived myocardial systolic srain rate is a strong index of left ventricular contractility. Circulation. 2002;105 (1):99–105.
  25. Breithardt OA, Stellbrink C, Herbots L et al. Cardiac resyncronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle block. J Am Coll Cardiol. 2003;42 (3):486–494.
  26. Kanzaki H, Bazaz R, Schwartzman D et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44 (8):1619–1625.
  27. Mele D, Pasanisi G, Capasso F et al. Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. Eur Heart J. 2006;27 (8):1070–1078.
  28. Yu CM, Chau E, Sanderson JE et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 2002;105 (4):438–445.
  29. Braunschweig F, Sörensen J, von Bibra H et al. Effects of biventricular pa­cing on myocardial blood flow and oxygen consumption using carbon-11 acetat positron emission tomography in patients with heart failure. Am J Cardiol. 2003;92 (1):95–99.
  30. Uemura T, Otsuji Y, Nakashiki K et al. Papillary muscle dysfunction attenu­ates ischemic mitral regurgitation in patients with localized basal inferior left ventricular remodeling: insights from tissue Doppler strain imaging. J Am Coll Cardiol. 2005;46 (1):113–119.
  31. Bleeker GB, Schalij MJ, Nihoyannopoulos P et al. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol. 2005;46 (12):2264–2269.
  32. Ghio S, Freemantle N, Serio A et al. Baseline echocardiographic characte­ristics of heart failure patients enrolled in a large Europen multicentre trial (Cardiac Resynchronisation Heart Failure Study). Eur J Echocardiogr. 2006;7 (5):373–378.
  33. Wikstrom G, Blomström-Lundqvist C, Andren B et al. The effects of aetio­logy on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J. 2009;30 (7):782–788.
  34. Porciani MC, Macioce R, Dearchi G et al. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur. J. Echocardiogr. 200;7:31–39.
  35. Yu CM, Zhang Q, Fung JW et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy to tissue synchronization imaging. J Am Coll Cardiol. 2005;45 (5):677–684.
  36. Bleeker GB, Bax JJ, Fung JW et al. Clinical versus echocardiograhic parame­ters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006;97 (2):260–263.
  37. Duncan AM, Lim E, Clague J et al. Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization. Eur Heart J. 2006;27 (20):2426–32.
  38. Parsai C, Bijnens B, Sutherland GR et al. Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms. Eur Heart J. 2009;30 (8):940–949.
  39. Higgins SL, Hummel JD, Niazi IK et al. Cardiac resynchronization therapy for the treatment of heart failure patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003;42 (8):1454–1459.
  40. Abraham WT, Young JB, Leon AR et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004;110 (18):2864–2868.
  41. Landolina M, Lunati M, Gasparini M et al. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync / InSync ICD Italian Registry). Am J Cardiol. 2007;100 (6):1007–1012.
  42. Cleland JG, Freemantle N, Daubert JC et al. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart. 2008;94 (3):278–283.
  43. Ng K, Kedia N, Martin D et al. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pa­cing. Pacing Clin Electrophysiol. 2007;30 (2):193–198.
  44. Pires LA, Abraham WT, Young JB et al. Clinical predictors and timing of NYHA class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the multicenter InSync randomized clinical evaluation (MIRACLE-ICD) trials. Am Heart J. 2006;151 (4):837–843.
  45. Linde C, Gold M, Abraham WT, Daubert JC; REVERSE Study Group. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure – the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J. 2006;151 (2):288–294.
  46. Moss AJ, Brown MW, Cannom DS et al. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005;10 (4 Suppl):34–43.
  47. Goscinska-Bis K, Bis J, Krejca M et al. Totally epicardial cardiac resynchronization therapy system implantation in patients with heart failure undergoing CABG. Eur J Heart Fail. 2008;10 (5):498–506.
  48. Gras D, Bocker D, Lunati M et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace. 2007;9 (7):516–522.
  49. Song ZZ. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodeling: a circumferential strain analysis based on 2D echocardiography. Eur Heart J. 2008;29 (5):684.
  50. Yu CM, Chan YS, Zhang Q et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexis­ting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48 (11):2251–2257.
  51. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337 (22):1569–1575.
  52. Achilli A, Sassara M, Ficili S et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and «narrow» QRS. J Am Coll Cardiol. 2003;42 (12):2117–2124.
  53. Krebanek M, Malek I, Bitesnik J et al. Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 month. Eur J Heart Fail. 2006;8 (8):832–840.
Atroshchenko E. S. Problems and prospects of cardiac resynchronization therapy in patients with chronic heart failure. Russian Heart Failure Journal. 2010;11(2):124-127.

To access this material please log in or register

Register Authorize
Ru En